XML 38 R7.htm IDEA: XBRL DOCUMENT v3.25.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net loss $ (100,710) $ (55,582)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation of property and equipment 234 352
Amortization of platform development and intangible assets 11,859 27,354
Amortization of debt costs 658 2,378
Noncash and accrued interest 3,824
Loss on impairment of assets 40,589 119
Loss on sale of assets 325
Change in valuation of contingent consideration 313 1,010
Liquidated damages 306 583
Stock-based compensation 3,031 19,060
Deferred income taxes 203 134
Bad debt expense 2,992 315
Other (19)
Change in operating assets and liabilities net of effect of acquisitions:    
Accounts receivable 10,478 (11,599)
Subscription acquisition costs 6,131 3,143
Prepayments and other current assets 1,841 (2,157)
Other long-term assets 852 (77)
Accounts payable (3,730) (2,663)
Accrued expenses and other 29,688 3,453
Unearned revenue (18,803) (7,970)
Subscription refund liability 404 (396)
Operating lease liability (304) (231)
Contingent consideration (1,683)
Other long-term liabilities (406) (6,147)
Net cash used in operating activities (16,076) (24,772)
Cash flows from investing activities    
Purchases of property and equipment (54)
Capitalized platform development (5,121) (3,773)
Proceeds from sale of assets 1,061
Payments for acquisitions, net of cash (500)
Net cash used in investing activities (5,175) (3,212)
Cash flows from financing activities    
Proceeds from bridge notes, net of debt costs 8,000
Payment of Fexy put option (561)
(Repayments) proceeds under line of credit (20,027) 5,517
Proceeds from common stock private placement 12,000
Proceeds from Simplify loan 25,651
Proceeds from common stock public offering, net of offering costs 11,500
Payments of issuance costs from common stock public offering (167)
Payments of debt issuance costs (457)
Payment of deferred cash payment (200) (75)
Payment for taxes related to common stock withheld for taxes (534) (1,423)
Net cash provided by financing activities 16,329 22,895
Net decrease in cash and cash equivalents (4,922) (5,089)
Cash and cash equivalents – beginning of year 9,284 14,373
Cash, and cash equivalents – end of year 4,362 9,284
Supplemental disclosure of cash flow information    
Cash paid for interest 17,837 12,101
Cash paid for income taxes 85 85
Noncash investing and financing activities    
Reclassification of stock-based compensation to platform development 259 1,016
Debt costs recorded in accrued expenses and other and in other long-term liabilities 189
Repurchase of common stock for Fexy put option 379
Issuance of common stock upon conversion of Series H convertible preferred stock 15,000
Issuance of common stock in connection with settlement of liquidated damages 499
Issuance of common stock upon conversion of series H preferred stock 13,008
Issuance of common stock in connection with an acquisition 2,000
Deferred cash payments recorded in connection with acquisitions 246
Assumption of liabilities in connection with acquisitions 1,246
Reclassification to liability upon common stock modification $ 68